University Malaysia Sarawak Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2016
NCT03459599
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Faculty of Medicine and Health Science, University Malaysia Sarawak | Universiti Malaysia Sarawak | University Malaysia Sarawak

Active Ingredients

Drugs in Phase 4 Trials (1)

vildagliptin (1 trial)

Drugs in Other Trials (3)

amoxicillin (1 trial)

clavulanate (Augmentin) (1 trial)

glucose (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4